Start Producing Sterile Water for Injection in Pharmaceutical Industry

Categories

Introduction:

Sterile water for injection, USP is a sterile, nonpyrogenic solution of water for injection. It contains no antimicrobial agents and does not contain added buffer salts. The pH of sterile water for injection, USP has been adjusted to 4.5 with hydrochloric acid or sodium hydroxide. It may be used in intravenous (IV) infusion solutions. Sterile water for injection (also known as sterile water) Itâ€™s available as an injection to be administered directly into a vein (intravenously) or muscle, and also as a liquid to be taken by mouth. Itâ€™s typically used for hydration purposes, but it can also be mixed with other solutions and injected into veins to deliver medications.

Visit this Page for More Information: Start a Business in Pharmaceutical sector

Uses

Sterile water injections are used to hydrate patients with severe burns or dehydration. These individuals may be so severely dehydrated that theyâ€™re unable to maintain enough hydration through oral intake. By injecting sterile water directly into a patientâ€™s bloodstream, medical professionals can help prevent deadly complications like heart attacks and kidney failure. This type of injection is often administered by trained oncology nurses in hospitals.

Business Plan: Business Plan on Production of Sterile Water for Injection

Individuals suffering from cancer may also receive sterile water intravenously before having chemotherapy administered. The procedure helps flush out impurities from their blood stream, allowing doctors to provide them with higher dosages of medication without risking serious side effects such as seizures or cardiac arrest.

Manufacturing Process:

Sterilization and filtration are the two main phases in the production of sterile water. To prevent contamination of equipment or unsterilized product, both procedures must be accomplished by qualified and licenced personnel utilising cutting-edge technology. Medical-grade water is purified by a five-stage reverse osmosis process in the first step. When a seven-stage system is used, an additional ozone disinfection step is performed.

Read Similar Articles: Pharmaceutical Industry

After that, the filters are sterilised in an autoclave before being used in the second phase. After filtration, the second phase employs UV radiation mixed with high temperatures to kill any bacteria that remain. There’s no possibility of germs developing resistance to UV light because UV rays contact each component of a filter at various times. When parts need to be replaced, sterility isn’t jeopardised because each filter is individually treatedâ€”no new filters have to be made from scratch just for those instances.

Read our Books Here: Pharmaceutical, Drugs, Proteins Technology Handbooks

Market Outlook:

The global market for sterile water products is forecast to reach US$ 738.9 million by 2022, Growing awareness of sterility and safety in injections will propel market growth over next six years. The rising incidence of infectious diseases and growing geriatric population base globally has resulted in increasing demand for sterile water solutions that can protect patients from unwanted infections and other related ailments post-injections.

India’s biotechnology industry comprising biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics is expected grow at an average growth rate of around 30 per cent a y-o-y to reach US$ 100 billion by 2025.

Watch other Informative Videos: Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs

The increase of lifestyle diseases in India such as diabetes and heart disease has heightened the demand for medicines. There is a large pool of scientific and research expertise in India, and an enormous population with high incidences of cancer and chronic disease. The shorter recruitment time-frames and lower costs make India an ideal setting for drug development and clinical trials.

Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal products and surgical.

Key Players: